Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus
  • PFAS in Water
  • Tear Gas and ICE Raids

WHAT'S NEW

  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus
  • PFAS in Water
  • Tear Gas and ICE Raids

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Mar 19 2018

Full Issue

Indictments Announced In Federal Probe Into 'Nationwide Conspiracy' Over Opioid Marketing Tactics

Along with the indictments, two Insys Therapeutics sales employees have agreed to cooperate with officials in the investigation, a signal that feds may be moving closer to building a case against executives at the drug company.

The New York Times: 5 Doctors Are Charged With Taking Kickbacks For Fentanyl Prescriptions

In March of 2013, Gordon Freedman, a doctor on Manhattan’s Upper East Side, fielded a request from a regional sales manager for the manufacturer of Subsys, a spray form of the highly addictive painkiller fentanyl. Dr. Freedman was already a top prescriber of Subsys and also one of the company’s paid promotional speakers. Now the sales manager was telling him the company, Insys Therapeutics, would increase the amount of money it was paying him and asked that he increase the number of new patients he was prescribing Subsys. (Weiser and Thomas, 3/16)

Stat: Former Insys Employees Agree To Cooperate With The Feds In Kickback Probe

Two former Insys Therapeutics sales employees have agreed to cooperate with a federal government probe that prosecutors have described as a “nationwide conspiracy” to profit from illegally distributing an opioid medication. Jonathan Roper, a former district sales manager, and Fernando Serrano, a former sales representative, also pleaded guilty to paying kickbacks to doctors in order to boost prescriptions for the Subsys painkiller, which contains fentanyl, a powerful and addictive opioid, prosecutors said Friday. In addition, the feds disclosed indictments of five New York doctors for taking kickbacks. (Silverman, 3/16)

The Associated Press: Q&A: Holding Drugmakers Accountable for the Opioid Crisis

Hundreds of communities in the U.S. are suing the makers and distributors of opioid painkillers, arguing that the companies should help pay the enormous costs of the deadliest drug epidemic in U.S. history. Since 2000, more than 340,000 Americans have died from overdoses of opioids, which include prescription painkillers and illegal drugs like heroin. The financial toll has been estimated at $500 billion in 2015, according to the latest White House figures, which include deaths, health care, lost productivity and criminal justice costs. (Perrone, 3/18)

In other news on the epidemic —

The New York Times: Palliative Care Film Challenges Stereotypes About Opioids

“Hippocratic,” a documentary about the life of Dr. M.R. Rajagopal, India’s leading advocate of palliative care, is now touring the United States — a country where attitudes toward pain relief have changed because of the overdose epidemic. Dr. Rajagopal’s chief message — and that of the film — is that the essence of care for the dying is simple compassion. His inspiration came from Mahatma Gandhi, said Dr. Rajagopal, who in 2014 won a global award from Human Rights Watch for his activism. (McNeil, 3/16)

Nashville Tennessean: Nashville Company Battling Opioid Addictions Raises $8 Million

180 Health Partners, a Nashville-based behavioral health company battling the opioid epidemic, has raised $8 million to fund its expansion and help mothers and newborns in more states. 180 Health Partners, led by CEO Justin Lanning, provides access to medical and behavioral health care to pregnant mothers struggling with opioid use and helps them give birth to healthy babies.  (McGee, 3/18)

Columbus Dispatch: Program Aims To Help Opioid-Addicted Parents Keep Kids

The START project (Sobriety, Treatment and Reducing Trauma) is primarily funded by $3.5 million in federal grant money passed through Ohio Attorney General Mike DeWine’s office. The goal is to keep children of drug-addicted parents at home and out of foster care, provided their parents undergo the treatment, counseling and other hard work required to get and stay clean. (Lane, 3/18)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Thursday, May 7
  • Wednesday, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
  • Thursday, April 30
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF